| Revenue growth | Q2 revenue from ops +10.0% YoY (Rs1,120Mn vs Rs1,018Mn) |
|---|---|
| Margins | Q2 EBITDA margin 35.5% vs 35.3% YoY; PAT margin 17.9% vs 19.1% |
| Demand visibility | Only industry TAM slides; no company visibility commentary |
Growth
Q2 revenue from operations Rs1,120Mn vs Rs1,018Mn (+10.0%); EBITDA +10.5%, PAT +3.5%. H1 revenue Rs2,211Mn (+10.9%), EBITDA +13.2%, PAT +7.3%.
Outlook
No explicit guidance or targets stated. Q2 capex cash outflow Rs92Mn; H1 total capex Rs272Mn.
Risks
PAT margin fell to 17.9% from 19.1% YoY. Depreciation (+26%) and material/testing costs (+30%) outpaced revenue growth. QoQ EBITDA and PAT declined.
Investor Presentation filed with BSE, NSE: VIMTALABS. Summary written with AI assistance from the document.
Vimta Labs Ltd: key numbers
- Share price
- ₹500.70
- Market cap
- ₹2,238 Cr
- Revenue (annual)
- ₹407.3 Cr
- Net profit (annual)
- ₹77.51 Cr
- P/E (TTM)
- 28.1×Sector 52.3×
- Promoter holding
- 35.64%-0.03% QoQ
- FII holding
- 5.07%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Vimta Labs Ltd
All →Vimta Labs Earnings Call Transcript: Key Takeaways
Stable Q2 performance masked by R&D lulls and logistics headwinds.
- Call
- Guides 25% growth
Vimta Labs Results Update
Vimta Labs reported Q2 FY27 income of ₹1,149 Mn, up 9.9% YoY, and PAT of ₹206 Mn at 17.9% margin. EBITDA margins held steady at 35.5%.
Vimta Labs Q2 FY27 Results: Net Profit ₹20.6 Cr, Up 3.5% YoY
Vimta Labs Ltd reported revenue from operations of ₹112 Cr (+10.0% YoY) and net profit of ₹20.6 Cr (+3.5% YoY) for Q2 FY27.
- Key figure
- Net profit ₹20.6 Cr · +3.5% YoY
Vimta Labs Board Meeting Date
Vimta Labs will hold a board meeting on 30 October 2026 to consider half-year results. Trading window stays closed from 01 October.
Vimta Labs Other Announcement
Vimta Labs Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI regulatory requirements.
Vimta Labs Employee Stock Options
Vimta Labs allotted 12,955 ESOP shares under its 2021 plan. Paid-up capital rose to ₹8,93,99,718, raising dilution for shareholders.